scholarly journals A Retrospective Observational Study on Receptor Status and Co-Morbidities or History of Thyroid Disorders And/Or Gallbladder Stones Associated With Breast Cancer Patients.

2021 ◽  
Vol 11 (2) ◽  
pp. 1-4
Author(s):  
Divya Panthi et al., Divya Panthi et al., ◽  
Keyword(s):  
Breast Cancer ◽  
Observational Study ◽  
Cancer Patients ◽  
Retrospective Observational Study ◽  
Thyroid Disorders ◽  
Breast Cancer Patients ◽  
Receptor Status ◽  
Gallbladder Stones ◽  
History Of ◽  
Or History

scholarly journals Association of Oral Contraceptives use with Breast Cancer and Hormone Receptor Status in Iraqi Women

2020 ◽  
Vol 8 (B) ◽  
pp. 1244-1250
Author(s):  
Ahmed Z. Alsammarraie ◽  
Ahmed A. Mubarak ◽  
Ahmed S. Alnuaimi ◽  
Areege M. Kamal
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Oral Contraceptives ◽  
Hormone Receptor ◽  
Hormone Receptor Status ◽  
Breast Cancer Patients ◽  
Receptor Status ◽  
History Of ◽  
Iraqi Women ◽  
Hormonal Receptor Status

BACKGROUND: Worldwide, there is a significant concern regarding the association of breast cancer risk and oral contraceptives use. Differences in demographical and pathological breast cancer characteristics in Iraqi patients have been reported compared to other western countries; however, studies addressing the risk of breast cancer among oral contraceptive users in Iraq and subsequent correlation with hormonal receptor status are lacking. AIM: The aim of the study was to evaluate association of breast cancer risk and oral contraceptives use in patients visiting tertiary oncology center and to correlate hormone receptor status with history of oral contraception use in breast cancer patients. PATIENTS AND METHODS: Two hundred women with breast cancer were compared regarding patterns of oral contraceptives use with 300 age-matched healthy female controls by personal interview and questionnaire. Patient’s records were reviewed for hormone receptor status. RESULTS: A significantly higher proportion (49%) of women with breast cancer reported a positive history of combined oral contraceptives use as compared with (35.7%) healthy controls. Ever oral contraceptives users had a significantly increased risk of breast cancer (odds ratio [OR] = 1.73; 95%, confidence interval = 1.2–2.5, p = 0.003), with the highest risk was seen in early use before the age of 20 (OR = 6.62, p = 0.02); whereas increased duration of use did not significantly increase the risk of breast cancer. There was no significant association between estrogen and progesterone receptors expression profile in breast cancer patients and combined oral contraceptive use. CONCLUSION: In Iraqi women, the risk of breast cancer increases with oral contraceptives intake particularly when starts early before the age of 20 years. The hormonal receptor status of breast cancer patients is not significantly affected by combined oral contraceptives use.

scholarly journals Chemotherapy-Induced Nausea and Vomiting Breast Cancer Patients from a Chinese Multicenter Prospective Longitudinal Observational Study

2021 ◽  
Author(s):  
Xin-Juan Huang ◽  
Xu-Ying Li ◽  
Lu Luo
Keyword(s):  
Breast Cancer ◽  
Risk Factors ◽  
Observational Study ◽  
Cancer Patients ◽  
Nausea And Vomiting ◽  
Breast Cancer Patients ◽  
History Of ◽  
Delayed Cinv ◽  
Acute Cinv ◽  
Prospective Longitudinal

Aims: To assess the occurrence of Chemotherapy-induced nausea and vomiting (CINV) after standard antiemetic therapy in the acute (24 h post-chemotherapy) and delayed (2–5 days post-chemotherapy) phases, as well as to identify risk factors for CINV in the acute and delayed phases. Methods: This prospective longitudinal and observational study analyzed the data of 400 breast cancer patients scheduled for chemotherapy over two cycles in two hospitals. The self-report survey was developed to assess the occurrence of CINV and their associated factors. CINV was evaluated with a Multinational Association of Supportive Care in Cancer Antiemetic Tool (MAT) on days 2 and 6 of chemotherapy. The incidence of acute and delayed CINV were presented by frequency and percentage. Generalized equation estimates (GEE) was used to identify risk factors of acute and delayed CINV. Results: There were 400 evaluable patients with complete Round 1 data, 334 for Round 2 data. Among 400 patients, 29.8% and 23.5% experienced acute and delayed CINV, respectively. Risk factors associated with for acute CINV were pain/insomnia, history of CINV, history of motion sickness (MS), and highly emetogenic chemotherapy regimen, while history of MS, CINV history, number of completed chemotherapy cycle number < 3, and the incidence of acute CINV were risk factors of delayed CINV (all p < 0.05). Conclusions: The findings may help nurses working for Chinese population in identifying patients at risk for CINV and in planning effective program to reduce the occurrence of CINV.

scholarly journals Eribulin Mesylate in Pretreated Breast Cancer Patients: A Multicenter Retrospective Observational Study

2014 ◽  
Vol 5 (5) ◽  
pp. 320-327 ◽  
Author(s):  
Teresa Gamucci ◽  
Andrea Michelotti ◽  
Laura Pizzuti ◽  
Lucia Mentuccia ◽  
Elisabetta Landucci ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Observational Study ◽  
Cancer Patients ◽  
Retrospective Observational Study ◽  
Breast Cancer Patients ◽  
Eribulin Mesylate
Sign in / Sign up

Export Citation Format

Share Document